AB1MALT : Bronchoscopic microwave ablation of Lung Tumours
Status: Recruiting
This is a post-market, prospective, single-arm, multicentre, non-randomized study which enrolling up to 32 subjects in total (plus replacements). The primary purpose of this study is to evaluate the safety and feasibility of the Creo Medical MicroBlate™ Flex AB1 instrument used with the AB1 electrosurgical system in patients undergoing bronchoscopic microwave ablation of peripheral lung nodules. Subjects include patients with a suitable soft tissue lung lesion, who are not surgical candidates or decline surgery. Subjects who meet the eligibility requirements undergo a pre-procedural assessment, a bronchoscopy procedure that includes ablation treatment with MicroBlate™ Flex AB1, a post-procedural assessment and 6 follow-up visits at, 7 days (by phone call or in person), 31-45 days, 3 months, 6 months, 9 months and 12 months.